Union Minister of Commerce & Industry Shri Piyush Goyal to visit Switzerland from June 12-13, 2026

1. At a Glance

• Union Minister of Commerce & Industry Piyush Goyal's visit to Berne, Switzerland (12 June 2026) to engage Swiss government and pharma industry leaders on implementation of the India–EFTA Trade and Economic Partnership Agreement (TEPA) [1].
• TEPA is India's first FTA with a legally binding investment-and-jobs commitment — a template for future Indian FTAs [3][4].
• Relevant for GS-II (bilateral/multilateral agreements) and GS-III (external sector, FDI, trade).

2. Why in the News

• Goyal's bilateral visit to Switzerland on 12 June 2026 to drive TEPA implementation, with focus on Swiss pharmaceutical industry engagement [1].
• Comes ~8 months after TEPA entered into force on 1 October 2025 [2][5].

3. Background & Evolution

• EFTA: European Free Trade Association — intergovernmental org of Switzerland, Norway, Iceland, Liechtenstein (non-EU European bloc) [1][3].
• Negotiations for India–EFTA TEPA spanned ~16 years before conclusion.
• Signed: 10 March 2024, New Delhi [3].
• Entry into force: 1 October 2025 [2][5].
• India–EFTA Desk inaugurated to facilitate investments [6].

4. Core Static Facts

• Agreement: India–EFTA Trade and Economic Partnership Agreement (TEPA) [1].
• Signed: 10 March 2024; In force: 1 October 2025 [2][3].
• Implementing Ministry (India): Ministry of Commerce & Industry, Department of Commerce [1].
• Structure: 14 chapters — market access, rules of origin, trade facilitation, SPS, TBT, investment promotion, services, IPR, trade & sustainable development [3][4].
• Investment commitment (Article 7.1): EFTA to facilitate USD 50 billion FDI in 10 years + additional USD 50 billion in next 5 years = USD 100 billion over 15 years (excludes FPI) [3].
• Jobs commitment: 1 million direct jobs in India [3][5].
• Tariff offers: India — 82.7% of tariff lines (covering 95.3% of EFTA exports); EFTA — 92.2% of tariff lines (covering 99.6% of India's exports) [4].
• Services sub-sectors offered: India offered 105; secured commitments — Switzerland 128, Norway 114, Iceland 110, Liechtenstein 107 [4].
• Exclusion list: dairy, soya, coal, pharmaceuticals, medical devices, select processed foods (to protect PLI sectors) [4].

5. Multi-Dimensional Analysis

Economic

• USD 100 bn FDI target over 15 years from EFTA, with verifiable review mechanism [3].
• Switzerland is India's largest EFTA trade partner; major sectors: pharma, machinery, precision instruments, gold imports.
• Indian services exports (IT, business, audio-visual, education) gain treaty-anchored access [4].

Geopolitical / Strategic

• First trade pact India has concluded with a developed European bloc — sets precedent for ongoing India–EU FTA negotiations [1].
• Diversifies India's Western engagement beyond US/EU; positions India in non-EU European supply chains.
• Goyal's visit signals high-level political continuity in implementation [1].

Legal / IPR

• IPR chapter with Switzerland — high-standard regime — yet protects India's generic medicines industry and addresses evergreening of patents concerns [4].
• TRIPS-compatible flexibilities preserved.

Scientific / Technological

• Cooperation envisaged in pharma, medtech, precision machinery, green tech [5].
• Swiss pharma industry engagement aligned with India's bulk drug/API self-reliance goals (Bulk Drug Parks, PLI) [4].

Administrative

• Implementation tracked via India–EFTA Desk [6].
• Commerce Secretary-level engagement with Norway and other EFTA states ongoing [7].

6. Recent Developments (last 12–18 months)

• 10 March 2024: TEPA signed in New Delhi [3].
• 2024: India–EFTA Desk inaugurated to channel investments [6].
• 1 October 2025: TEPA entered into force [2][5].
• 2025: Goyal urged Indian industry to leverage TEPA's USD 100 bn FDI/1 mn jobs framework [8].
• 12 June 2026: Goyal's Berne visit for implementation review with Swiss government and pharma leaders [1].

7. Prelims Hooks

• TEPA signed on 10 March 2024, in force from 1 October 2025 [2][3].
• EFTA members: Switzerland, Norway, Iceland, Liechtenstein (NOT EU members) [1].
• Investment commitment: USD 100 billion over 15 years, excluding FPI [3].
• Jobs target: 1 million direct jobs in India [3].
• TEPA has 14 chapters [3].
• India's tariff offer: 82.7% of tariff lines; EFTA's offer: 92.2% [4].
• Investment-linked commitment is in Article 7.1 of TEPA [3].
• India secured 128 services sub-sectors from Switzerland — highest among EFTA states [4].
• Dairy, soya, coal, pharmaceuticals, medical devices kept in exclusion list to protect PLI [4].
• Implementing ministry: Ministry of Commerce & Industry (Department of Commerce) [1].
• TEPA is first Indian FTA with binding investment/jobs target [3].
• IPR chapter explicitly addresses evergreening of patents concerns [4].

8. Mains Relevance

• GS-II: India and its neighbourhood / bilateral & regional groupings affecting India's interests; effect of policies of developed countries on India.
• GS-III: Indian economy — effects of liberalization, FDI, external sector, growth & employment.

Plausible question stems:

1. "The India–EFTA TEPA marks a paradigm shift by embedding binding investment and employment commitments in an Indian FTA. Discuss its significance and implementation challenges." (GS-III, 15 marks)
2. "Examine how India's IPR architecture under TEPA balances obligations to high-standard regimes like Switzerland with the imperative of protecting the generic pharmaceutical industry." (GS-II/III, 10 marks)
3. "EFTA is not the EU — yet TEPA can serve as a template for the India–EU FTA. Analyse." (GS-II, 15 marks)

9. Related Topics to Study Next

• India–EU FTA negotiations — TEPA is a stepping stone.
• India–UK FTA — comparator with developed-economy FTA.
• India–Australia ECTA & CECA — investment-light FTAs to contrast.
• PLI Scheme (pharma, medical devices) — sectors protected via TEPA exclusion list.
• TRIPS & patent evergreening (Sec 3(d) Patents Act 1970) — IPR backdrop.
• Bulk Drug Parks / API self-reliance — Swiss pharma engagement angle.
• EFTA vs EU vs EEA — structural distinction.
• Generalized System of Preferences (GSP) — alternative trade preference framework.

10. Common Errors / Trap Areas

• EFTA ≠ EU ≠ EEA: EFTA has 4 members; only Switzerland is non-EEA. Don't conflate with European Union.
• Signing vs entry into force: signed March 2024, in force October 2025 — both are testable.
• USD 100 bn = FDI only, NOT portfolio (FPI) — a common trap.
• Implementing ministry: Department of Commerce (MoCI), NOT MEA.
• TEPA's jobs target is "direct jobs" (1 million), not total/indirect.